Literature DB >> 3985598

Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

H Yamada, T Iwanaga, H Nakanishi, M Yamaguchi, K Iida.   

Abstract

The penetration of cefoperazone and moxalactam into pleural fluid was studied in 11 patients after intravenous infusion of 2-g doses of these agents. Clearance of these agents from pleural fluid was studied in seven patients after instillation of 1-g doses into the pleural space. The concentrations in pleural fluid after intravenous infusion of 2-g doses reached a peak of 7 to 25 micrograms/ml for cefoperazone and 9 to 35 micrograms/ml for moxalactam at 4 to 6 h after administration. These levels exceeded reported MICs for most susceptible organisms. The elimination half-life of both agents was about two to five times longer in pleural fluid than in serum. These prolonged elimination rates of both agents might be of great advantage for killing bacteria in the pleural space.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985598      PMCID: PMC176211          DOI: 10.1128/AAC.27.1.93

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Antibiotic penetrance of ascitic fluid in dogs.

Authors:  D N Gerding; J P Kromhout; J J Sullivan; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

2.  Penetration of cefazolin into pleural fluid.

Authors:  D R Cole; J Pung
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

3.  Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid of dogs.

Authors:  N G Waterman; M J Raff; L Scharfenberger; P A Barnwell
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

4.  Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

Authors:  R N Jones; P C Fuchs; A L Barry; T L Gavan; E H Gerlach; H M Sommers
Journal:  Clin Ther       Date:  1980       Impact factor: 3.393

5.  Penetration of cefuroxime and doxycycline into the pleural fluid.

Authors:  B Hoffstedt; B Ode; M Walder; A Hanson; P Christensson; S Cronberg
Journal:  J Antimicrob Chemother       Date:  1980-01       Impact factor: 5.790

6.  Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits.

Authors:  D N Gerding; W H Hall; E A Schierl; R E Manion
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

7.  Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Authors:  H C Neu; N Aswapokee; K P Fu; P Aswapokee
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

9.  Ascitic fluid cephalosporin concentrations: influence of protein binding and serum pharmacokinetics.

Authors:  D N Gerding; L R Peterson; D C Legler; W H Hall; E A Schierl
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

10.  LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

View more
  1 in total

1.  Penetration of amphotericin B lipid formulations into pleural effusion.

Authors:  Stefan Weiler; Rosa Bellmann-Weiler; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.